Anixa Biosciences, Inc. (ANIX)

3.66 +0.04 (+1.10%) USD  |  NASDAQ  |  Aug 25, 16:00
3.73 +0.07 (+1.91%) After-Hours: 19:59
More

Anixa Biosciences EPS Estimates for 2 Fiscal Years Ahead

EPS Estimates for 2 Fiscal Years Ahead Chart

View EPS Estimates for 2 Fiscal Years Ahead for ANIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for 2 Fiscal Years Ahead Chart
Start Trial

Historical EPS Estimates for 2 Fiscal Years Ahead Data

View and export this data back to 2022. Start Trial.
Date Value
March 16, 2026 --
January 21, 2026 --
Date Value
September 17, 2025 --
December 23, 2022 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for 2 Fiscal Years Ahead Range, Past 5 Years

View EPS Estimates for 2 Fiscal Years Ahead Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for 2 Fiscal Years Ahead Benchmarks

View EPS Estimates for 2 Fiscal Years Ahead Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Vicapsys Life Sciences, Inc. --